Literature DB >> 6297336

Relevance of changes in adrenoceptor characteristics after terbutaline treatment.

G K Terpstra, G A Wassink, J A Raaijmakers.   

Abstract

Rats were treated with terbutaline in order to specify the in vivo effects of beta 2-sympathicomimetic treatment in relation with desensitization phenomena on the level of pulmonary adrenoceptors. Maximal binding of 3H-dihydroalprenolol (3H-DHA) to lung membrane preparations, binding affinity and the relative amount of beta 2-adrenoceptors were used as parameters. These were established 1, 3, and 6 days after a 10 days terbutaline treatment and compared with control values. Ten days treatment did not cause significant changes in the parameters measured. However, maximal binding was enhanced 3 and 6 days after the last treatment, binding affinity was enhanced 3 days after the last treatment, while the relative amount of beta 2-adrenoceptors was diminished 1 and 6 days after termination of the treatment. When the amount of beta 2-adrenoceptors was calculated in terms of 3H-DHA binding, an increase could be shown 3 days after the last terbutaline treatment. Therefore the direct influence of the treatment on the beta-adrenoceptor population appeared to be small, dependent on the parameter used and probably not eliciting a functional desensitization.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6297336

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  1 in total

1.  Beta-agonistic properties of tulobuterol, a new beta-sympathicomimetic drug, and its effects on pulmonary beta-adrenoceptor characteristics.

Authors:  G K Terpstra; J A Raaijmakers
Journal:  Lung       Date:  1990       Impact factor: 2.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.